{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:58:24Z","timestamp":1791475104810,"version":"4.3.4"},"reference-count":99,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["26E0143"],"award-info":[{"award-number":["26E0143"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["26V0140"],"award-info":[{"award-number":["26V0140"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and ICT and Ministry of Health & Welfare","award":["RS-2024-00467483"],"award-info":[{"award-number":["RS-2024-00467483"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interleukin-17A (IL-17A) is a proinflammatory cytokine that occupies a central position at the interface of host defense, tissue homeostasis, and chronic inflammation. While IL-17A plays essential roles in antimicrobial immunity and epithelial barrier integrity, dysregulated IL-17A signaling drives the pathogenesis of autoimmune and inflammatory diseases. This functional duality underlies both the clinical success and the inherent limitations of IL-17A signaling-neutralizing therapies, highlighting the need for selective and context-dependent modulation. In this perspective, we provide an overview of IL-17A signaling, from cytokine production to receptor-proximal signal transduction and therapeutic intervention. We then discuss small-molecule IL-17A antagonists identified through structure-guided approaches, with an emphasis on key binding modes, and briefly summarize compounds discovered through assay-based strategies. Beyond antagonism, we also examine the emerging concept of IL-17RA agonism, which remains largely unexplored. Collectively, this perspective highlights the importance of context-dependent small-molecule modulation of IL-17A signaling.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01296","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:02:34Z","timestamp":1790352154000},"page":"21673-21696","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the IL-17A Cytokine Interface: Structural Insights and Small-Molecule Modulators"],"prefix":"10.1021","volume":"69","author":[{"given":"Gyeong Un","family":"Kim","sequence":"first","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]},{"name":"University of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-4301","authenticated-orcid":true,"given":"Ansoo","family":"Lee","sequence":"additional","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]},{"name":"University of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7765-5916","authenticated-orcid":true,"given":"Sanghee","family":"Lee","sequence":"additional","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]},{"name":"Kyung Hee University , , ,","place":["Seoul, Republic of Korea, 02447"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4189-6774","authenticated-orcid":true,"given":"Byungsun","family":"Jeon","sequence":"additional","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]},{"name":"University of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-1912","authenticated-orcid":true,"given":"Hahnbeom","family":"Park","sequence":"additional","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7066-7642","authenticated-orcid":true,"given":"Taek","family":"Kang","sequence":"additional","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]},{"name":"University of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-2678","authenticated-orcid":true,"given":"Hyunah","family":"Choo","sequence":"additional","affiliation":[{"name":"Korea Institute of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]},{"name":"University of Science and Technology , , ,","place":["Seoul, Republic of Korea, 02792"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"2","key":"2026100811064591200_cit1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional Specialization of Interleukin-17 Family Members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"2026100811064591200_cit2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 Family of Cytokines in Health and Disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"2026100811064591200_cit3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 Family in Diseases: From Bench to Bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"2026100811064591200_cit4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and Signalling in the IL-17 Receptor Family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"2026100811064591200_cit5","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 Receptor\u2212Based Signaling and Implications for Disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"2026100811064591200_cit6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 Family: Cytokines, Receptors and Signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"2026100811064591200_cit7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-Producing Cells in Protection versus Pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"2026100811064591200_cit8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"9","key":"2026100811064591200_cit9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","article-title":"The Role of IL-17A in Axial Spondyloarthritis and Psoriatic Arthritis: Recent Advances and Controversies","volume":"78","author":"McGonagle","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"2026100811064591200_cit10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4049\/jimmunol.1500909","article-title":"IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida Albicans","volume":"195","author":"Conti","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"2026100811064591200_cit11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The Safety and Side Effects of Monoclonal Antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"2026100811064591200_cit12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/13543776.2022.2143264","article-title":"Small Molecule Modulators of IL-17A\/IL-17RA: A Patent Review (2013-2021). Expert Opin","volume":"32","author":"Zhang","year":"2022","journal-title":"Ther. Pat."},{"issue":"4","key":"2026100811064591200_cit13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1208\/s12248-012-9388-8","article-title":"Challenges and Opportunities in Absorption, Distribution, Metabolism, and Excretion Studies of Therapeutic Biologics","volume":"14","author":"Xu","year":"2012","journal-title":"AAPS J."},{"issue":"1","key":"2026100811064591200_cit14","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/ncomms2880","article-title":"Crystal Structures of Interleukin 17A and Its Complex with IL-17 Receptor A","volume":"4","author":"Liu","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"2026100811064591200_cit15","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1021\/acs.jmedchem.5b01693","article-title":"A Binding Site on IL-17A for Inhibitory Macrocycles Revealed by Hydrogen\/Deuterium Exchange Mass Spectrometry","volume":"59","author":"Espada","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026100811064591200_cit16","doi-asserted-by":"publisher","first-page":"30859","DOI":"10.1038\/srep30859","article-title":"Binding Site Elucidation and Structure Guided Design of Macrocyclic IL-17A Antagonists","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"2026100811064591200_cit17","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1021\/acs.jmedchem.3c02397","article-title":"Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to in Vivo Active Compounds","volume":"67","author":"Ramos","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026100811064591200_cit18","doi-asserted-by":"publisher","first-page":"14561","DOI":"10.1038\/s41598-022-18760-1","article-title":"Identification and Structure-Based Drug Design of Cell-Active Inhibitors of Interleukin 17A at a Novel C-Terminal Site","volume":"12","author":"Goedken","year":"2022","journal-title":"Sci. Rep."},{"issue":"13","key":"2026100811064591200_cit19","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1021\/acs.jmedchem.2c00422","article-title":"Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein-Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases","volume":"65","author":"Andrews","year":"2022","journal-title":"J. Med. Chem."},{"issue":"18","key":"2026100811064591200_cit20","doi-asserted-by":"publisher","first-page":"16692","DOI":"10.1021\/acs.jmedchem.4c01520","article-title":"Discovery and in Vivo Exploration of 1,3,4-Oxadiazole and \u03b1-Fluoroacrylate Containing IL-17 Inhibitors","volume":"67","author":"Velcicky","year":"2024","journal-title":"J. Med. Chem."},{"issue":"7","key":"2026100811064591200_cit21","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400851","article-title":"Thiazole-Based IL-17 Inhibitors Discovered by Scaffold Morphing","volume":"20","author":"Velcicky","year":"2025","journal-title":"ChemMedChem"},{"issue":"24","key":"2026100811064591200_cit22","doi-asserted-by":"publisher","first-page":"26494","DOI":"10.1021\/acs.jmedchem.5c02794","article-title":"Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 Inhibitors","volume":"68","author":"Bauer","year":"2025","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026100811064591200_cit23","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1021\/acsmedchemlett.5c00502","article-title":"A Novel Small Molecule Allosteric Inhibitor of IL-17A from a DNA-Encoded Library","volume":"16","author":"Milla","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"2026100811064591200_cit24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-022-01202-9","article-title":"IL-17 Signaling in Skin Repair: Safeguarding Metabolic Adaptation of Wound Epithelial Cells","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"2026100811064591200_cit25","doi-asserted-by":"publisher","first-page":"1284304","DOI":"10.3389\/fneur.2023.1284304","article-title":"Advances in the Study of IL-17 in Neurological Diseases and Mental Disorders","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Neurol."},{"issue":"6673","key":"2026100811064591200_cit26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic Cells and the Control of Immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"1","key":"2026100811064591200_cit27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"2026100811064591200_cit28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular Mechanisms of T Cell Co-Stimulation and Co-Inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"7090","key":"2026100811064591200_cit29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal Developmental Pathways for the Generation of Pathogenic Effector TH17 and Regulatory T Cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"13","key":"2026100811064591200_cit30","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.1074\/jbc.c600321200","article-title":"STAT3 Regulates Cytokine-Mediated Generation of Inflammatory Helper T Cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026100811064591200_cit31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The Orphan Nuclear Receptor RORgammat Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"2","key":"2026100811064591200_cit32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF-\u03b2 in the Context of an Inflammatory Cytokine Milieu Supports de Novo Differentiation of IL-17-Producing T Cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"10","key":"2026100811064591200_cit33","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 Are Coexpressed by Th17 Cells and Cooperatively Enhance Expression of Antimicrobial Peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"4","key":"2026100811064591200_cit34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of Interleukin 17 Receptor Signaling for Lung CXC Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense","volume":"194","author":"Ye","year":"2001","journal-title":"J. Exp. Med."},{"issue":"3","key":"2026100811064591200_cit35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 Mediates Mucosal Host Defense against Gram-Negative Bacterial Pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat. Med."},{"issue":"2","key":"2026100811064591200_cit36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 Drives a Pathogenic T Cell Population That Induces Autoimmune Inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"issue":"12","key":"2026100811064591200_cit37","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-\u03b2 and IL-6 Drive the Production of IL-17 and IL-10 by T Cells and Restrain TH-17 Cell-Mediated Pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat. Immunol."},{"issue":"9","key":"2026100811064591200_cit38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23\u2212IL-17 Immune Axis: From Mechanisms to Therapeutic Testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"2026100811064591200_cit39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"2026100811064591200_cit40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 Induce Innate IL-17 Production from \u03b3\u03b4 T Cells, Amplifying Th17 Responses and Autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"issue":"9","key":"2026100811064591200_cit41","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The Biology and Functional Importance of MAIT Cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat. Immunol."},{"issue":"8","key":"2026100811064591200_cit42","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/eji.202048645","article-title":"Interleukin-17 Producing Mucosal Associated Invariant T Cells - Emerging Players in Chronic Inflammatory Diseases?","volume":"50","author":"Pisarska","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"2026100811064591200_cit43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-Producing Cells: The Sentinels of the Immune System","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"2026100811064591200_cit44","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T Cell Interleukin-17 Induces Stromal Cells to Produce Proinflammatory and Hematopoietic Cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"issue":"3","key":"2026100811064591200_cit45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"issue":"7192","key":"2026100811064591200_cit46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-\u03b2-Induced Foxp3 Inhibits Th17 Cell Differentiation by Antagonizing ROR\u03b3t Function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"issue":"5","key":"2026100811064591200_cit47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s0968-0004(03)00067-7","article-title":"The STIR-Domain Superfamily in Signal Transduction, Development and Immunity","volume":"28","author":"Novatchkova","year":"2003","journal-title":"Trends Biochem. Sci."},{"issue":"47","key":"2026100811064591200_cit48","doi-asserted-by":"publisher","first-page":"35603","DOI":"10.1074\/jbc.c600256200","article-title":"Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor","volume":"281","author":"Chang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"2026100811064591200_cit49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1439","article-title":"The Adaptor Act1 Is Required for Interleukin 17-Dependent Signaling Associated with Autoimmune and Inflammatory Disease","volume":"8","author":"Qian","year":"2007","journal-title":"Nat. Immunol."},{"issue":"92","key":"2026100811064591200_cit50","doi-asserted-by":"publisher","first-page":"ra63","DOI":"10.1126\/scisignal.2000382","article-title":"Act1, a U-Box E3 Ubiquitin Ligase for IL-17 Signaling","volume":"2","author":"Liu","year":"2009","journal-title":"Sci. Signal."},{"issue":"6844","key":"2026100811064591200_cit51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 Is a Ubiquitin-Dependent Kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"issue":"10","key":"2026100811064591200_cit52","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.4049\/jimmunol.179.10.6504","article-title":"Requirement for Both JAK-Mediated PI3K Signaling and ACT1\/TRAF6\/TAK1-Dependent NF-\u03baB Activation by IL-17A in Enhancing Cytokine Expression in Human Airway Epithelial Cells","volume":"179","author":"Huang","year":"2007","journal-title":"J. Immunol."},{"issue":"19","key":"2026100811064591200_cit53","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1074\/jbc.m109.017129","article-title":"Induction of Neutrophil Gelatinase-Associated Lipocalin Expression by Co-Stimulation with Interleukin-17 and Tumor Necrosis Factor-\u03b1 Is Controlled by I\u03baB-\u03b6 but Neither by C\/EBP-\u03b2 nor C\/EBP-\u03b4","volume":"285","author":"Karlsen","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"42","key":"2026100811064591200_cit54","doi-asserted-by":"publisher","first-page":"27467","DOI":"10.1074\/jbc.273.42.27467","article-title":"Interleukin-17-Induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-Activated Protein Kinases and NF-\u03baB","volume":"273","author":"Shalom-Barak","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"37","key":"2026100811064591200_cit55","doi-asserted-by":"publisher","first-page":"27229","DOI":"10.1074\/jbc.m703250200","article-title":"Interleukin-17 Stimulates C-Reactive Protein Expression in Hepatocytes and Smooth Muscle Cells via P38 MAPK and ERK1\/2-Dependent NF-\u03baB and C\/EBP-\u03b2 Activation","volume":"282","author":"Patel","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"34","key":"2026100811064591200_cit56","doi-asserted-by":"publisher","first-page":"24138","DOI":"10.1074\/jbc.m604597200","article-title":"Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes","volume":"281","author":"Shen","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"2026100811064591200_cit57","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1074\/jbc.m308809200","article-title":"Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-\u03b1 Is Mediated by CCAAT\/Enhancer-Binding Protein Family Members","volume":"279","author":"Ruddy","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"2026100811064591200_cit58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/immunohorizons.1900023","article-title":"I\u03baB-\u03b6 Expression Requires Both TYK2\/STAT3 Activity and IL-17-Regulated mRNA Stabilization","volume":"3","author":"Muromoto","year":"2019","journal-title":"ImmunoHorizons"},{"issue":"9","key":"2026100811064591200_cit59","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 Prolongs the Half-Life of Chemokine CXCL1 mRNA via the Adaptor TRAF5 and the Splicing-Regulatory Factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat. Immunol."},{"issue":"2","key":"2026100811064591200_cit60","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4049\/jimmunol.1203315","article-title":"HuR Is Required for IL-17-Induced Act1-Mediated CXCL1 and CXCL5 mRNA Stabilization","volume":"191","author":"Herjan","year":"2013","journal-title":"J. Immunol."},{"issue":"551","key":"2026100811064591200_cit61","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aat4617","article-title":"IL-17 Integrates Multiple Self-Reinforcing, Feed-Forward Mechanisms through the RNA Binding Protein Arid5a","volume":"11","author":"Amatya","year":"2018","journal-title":"Sci. Signal."},{"issue":"4","key":"2026100811064591200_cit62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41590-018-0071-9","article-title":"IL-17-Receptor-Associated Adaptor Act1 Directly Stabilizes mRNAs to Mediate IL-17 Inflammatory Signaling","volume":"19","author":"Herjan","year":"2018","journal-title":"Nat. Immunol."},{"issue":"5","key":"2026100811064591200_cit63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.coi.2011.07.006","article-title":"Recent Advances in the IL-17 Cytokine Family","volume":"23","author":"Gaffen","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"2026100811064591200_cit64","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 Is a Chief Orchestrator of Immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat. Immunol."},{"issue":"6025","key":"2026100811064591200_cit65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"issue":"6276","key":"2026100811064591200_cit66","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The Maternal Interleukin-17a Pathway in Mice Promotes Autism-like Phenotypes in Offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"issue":"7673","key":"2026100811064591200_cit67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature23910","article-title":"Maternal Gut Bacteria Promote Neurodevelopmental Abnormalities in Mouse Offspring","volume":"549","author":"Kim","year":"2017","journal-title":"Nature"},{"issue":"7789","key":"2026100811064591200_cit68","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1843-6","article-title":"IL-17a Promotes Sociability in Mouse Models of Neurodevelopmental Disorders","volume":"577","author":"Reed","year":"2020","journal-title":"Nature"},{"issue":"6","key":"2026100811064591200_cit69","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1542\/peds.2007-0360","article-title":"Behaviors Associated with Fever in Children with Autism Spectrum Disorders","volume":"120","author":"Curran","year":"2007","journal-title":"Pediatrics"},{"issue":"5","key":"2026100811064591200_cit70","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 Signaling: The Yin and the Yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"issue":"2","key":"2026100811064591200_cit71","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cyto.2013.03.014","article-title":"The Activation and Regulation of IL-17 Receptor Mediated Signaling","volume":"62","author":"Song","year":"2013","journal-title":"Cytokine"},{"issue":"4","key":"2026100811064591200_cit72","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1056\/nejmoa1314258","article-title":"Secukinumab in Plaque Psoriasis\u2212Results of Two Phase 3 Trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"2026100811064591200_cit73","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/nejmoa1412679","article-title":"FUTURE 1 Study Group. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2026100811064591200_cit74","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"2026100811064591200_cit75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/nejmoa1512711","article-title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2026100811064591200_cit76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","article-title":"SPIRIT-P1 Study Group. Ixekizumab , an Interleukin-17A Specific Monoclonal Antibody, for the Treatment of Biologic-Naive Patients with Active Psoriatic Arthritis: Results from the 24-Week Randomised, Double-Blind, Placebo-Controlled and Active (Adalimumab)-Controlled Period of the Phase III Trial SPIRIT-P1","volume":"76","author":"Mease","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10163","key":"2026100811064591200_cit77","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","article-title":"Ixekizumab , an Interleukin-17A Antagonist in the Treatment of Ankylosing Spondylitis or Radiographic Axial Spondyloarthritis in Patients Previously Untreated with Biological Disease-Modifying Anti-Rheumatic Drugs (COAST-V): 16 Week Results of a Phase 3 Randomised, Double-Blind, Active-Controlled and Placebo-Controlled Trial","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"issue":"14","key":"2026100811064591200_cit78","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/nejmoa1503824","article-title":"Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2026100811064591200_cit79","doi-asserted-by":"publisher","first-page":"100075","DOI":"10.1016\/j.medidd.2020.100075","article-title":"Biologics vs. Small Molecules: Drug Costs and Patient Access","volume":"9","author":"Makurvet","year":"2021","journal-title":"Med. Drug Discov."},{"issue":"1","key":"2026100811064591200_cit80","doi-asserted-by":"publisher","first-page":"2177095","DOI":"10.1080\/09546634.2023.2177095","article-title":"Treatment Patterns and Healthcare Costs among Patients with Psoriasis Initiating Apremilast or Biologics: A Retrospective Claims Database Cohort Analysis","volume":"34","author":"Wu","year":"2023","journal-title":"J. Dermatolog. Treat."},{"issue":"12","key":"2026100811064591200_cit81","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1021\/acs.jmedchem.1c00327","article-title":"Macrolide Inspired Macrocycles as Modulators of the IL-17A\/IL-17RA Interaction","volume":"64","author":"Kos\u030ctrun","year":"2021","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026100811064591200_cit82","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/cpt.3185","article-title":"Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study","volume":"115","author":"Datta-Mannan","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"2026100811064591200_cit83","doi-asserted-by":"publisher","first-page":"103525","DOI":"10.1016\/j.jpet.2025.103525","article-title":"Small Molecule Interleukin (IL) 17A\/A Antagonists and Antibodies Blocking Both IL17A\/A and IL17A\/F Demonstrate Equivalent Degrees of Efficacy in Preclinical Models of Skin and Joint Inflammation","volume":"392","author":"Goedken","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026100811064591200_cit84","unstructured":"Taylor, M.; Terrett, N. K.; Connors, W. H.; Shortsleeves, K. C.; Seigal, B. A.; Snedeker, C.; Hale, S. P.; Briggs, T. F.; Favaloro, F. G.; Cipriani, T. J.; Yan, D.; Alexander, S. L.; Thorarensen, A.; Xing, L.\n          Macrocyclic Compounds for Modulating IL-17, WO 2013116682 A1, August 8, 2013."},{"issue":"1","key":"2026100811064591200_cit85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1039\/c4sc03089c","article-title":"Macrocycles: Lessons from the Distant Past, Recent Developments, and Future Directions","volume":"6","author":"Yudin","year":"2015","journal-title":"Chem. Sci."},{"issue":"7","key":"2026100811064591200_cit86","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1021\/jm1012374","article-title":"Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery","volume":"54","author":"Marsault","year":"2011","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026100811064591200_cit87","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1021\/acs.jmedchem.3c00134","article-title":"Macrocycles in Drug Discovery-Learning from the Past for the Future","volume":"66","author":"Garcia Jimenez","year":"2023","journal-title":"J. Med. Chem."},{"issue":"14","key":"2026100811064591200_cit88","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1021\/acs.jmedchem.7b01314","article-title":"Retinoic Acid Receptor-Related Orphan Receptor \u03b3t (ROR\u03b3t) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy","volume":"61","author":"Qiu","year":"2018","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026100811064591200_cit89","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/17460441.2017.1346608","article-title":"Stabilization of Protein-Protein Interactions in Drug Discovery","volume":"12","author":"Andrei","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"9","key":"2026100811064591200_cit90","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1021\/cr400698c","article-title":"Modulators of Protein-Protein Interactions","volume":"114","author":"Milroy","year":"2014","journal-title":"Chem. Rev."},{"issue":"9","key":"2026100811064591200_cit91","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/anie.201107616","article-title":"Small-Molecule Stabilization of Protein-Protein Interactions: An Underestimated Concept in Drug Discovery?","volume":"51","author":"Thiel","year":"2012","journal-title":"Angew. Chem., Int. Ed."},{"issue":"1","key":"2026100811064591200_cit92","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent Advances in the Development of Protein-Protein Interactions Modulators: Mechanisms and Clinical Trials","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"2026100811064591200_cit93","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.drudis.2020.07.012","article-title":"Noncellular Screening for the Discovery of Protein-Protein Interaction Modulators","volume":"25","author":"Kieffer","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"9","key":"2026100811064591200_cit94","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty Years on: The Impact of Fragments on Drug Discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"2026100811064591200_cit95","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/s0033583512000108","article-title":"Biophysical and Computational Fragment-Based Approaches to Targeting Protein-Protein Interactions: Applications in Structure-Guided Drug Discovery","volume":"45","author":"Winter","year":"2012","journal-title":"Q. Rev. Biophys."},{"issue":"8","key":"2026100811064591200_cit96","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1021\/jacs.8b11658","article-title":"Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers","volume":"141","author":"Sijbesma","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"48","key":"2026100811064591200_cit97","doi-asserted-by":"publisher","first-page":"21520","DOI":"10.1002\/anie.202008585","article-title":"Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based Tethering","volume":"59","author":"Wolter","year":"2020","journal-title":"Angew. Chem., Int. Ed."},{"issue":"1","key":"2026100811064591200_cit98","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-024-02036-3","article-title":"New Insights into Protein-Protein Interaction Modulators in Drug Discovery and Therapeutic Advance","volume":"9","author":"Nada","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"2026100811064591200_cit99","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/med.21585","article-title":"Emerging Roles of Allosteric Modulators in the Regulation of Protein-Protein Interactions (PPIs): A New Paradigm for PPI Drug Discovery","volume":"39","author":"Ni","year":"2019","journal-title":"Med. Res. Rev."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01296","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/21673\/68659585\/jm6c01296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/21673\/68659585\/jm6c01296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:31:05Z","timestamp":1791473465000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/19\/21673\/5438912\/Targeting-the-IL-17A-Cytokine-Interface-Structural"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":99,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,9,25]]},"published-print":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01296","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}